Current Price | $0.87 | Mkt Cap | $603.2M |
---|---|---|---|
Open | $0.90 | P/E Ratio | -3.44 |
Prev. Close | $0.87 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.86 - $0.91 | Volume | 33,350 |
52-Wk Range | $0.85 - $2.24 | Avg. Daily Vol. | 13,139,433 |
Current Price | $0.87 | Mkt Cap | $603.2M |
---|---|---|---|
Open | $0.90 | P/E Ratio | -3.44 |
Prev. Close | $0.87 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.86 - $0.91 | Volume | 33,350 |
52-Wk Range | $0.85 - $2.24 | Avg. Daily Vol. | 13,139,433 |
The best Bull and Bear pitches based on recency and number of recommendations.
Their 4KScore Test accurately predicts prostate cancer risk has received insurance classificationTheir drug Rayaldee with a +$10B market potential completed phase 3 trials and an NDA was submitted to to the FDA last May we approval expect in… More
Uses known stock promoter Redchip.com. Is a pump and dump scam.
Read the most recent pitches from players about OPK.
Recs
COVID NOT GOING TO VR A FACTOR IN 5 years
Recs
COVID has created an opportunity for this company to dissolve itself and do right by shareholders. I don't think they will do it. The testing business will be commoditized and I don't see any breakthroughs on the drug side of the business.
Recs
Undervalued.
Find the members with the highest scoring picks in OPK.
avatre (< 20) Score: +500.01
The Score Leader is the player with the highest score across all their picks in OPK.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
avatre | < 20 | 6/15/2009 | 5Y | $1.68 | -48.48% | +451.53% | +500.01 | 0 Comment | ||
gmxBatteringRam | 27.48 | 8/5/2009 | 5Y | $2.05 | -57.78% | +415.62% | +473.40 | 0 Comment | ||
shorttest4 | 58.06 | 3/8/2010 | 5Y | $2.06 | -57.99% | +348.85% | +406.84 | 0 Comment | ||
haimp | < 20 | 10/7/2010 | 5Y | $2.31 | -62.53% | +342.69% | +405.23 | 0 Comment | ||
EcoUSA | 64.84 | 11/12/2010 | 5Y | $2.95 | -70.66% | +324.48% | +395.14 | 0 Comment | ||
nearo | < 20 | 8/1/2008 | 3M | $1.82 | -52.45% | +320.55% | +372.99 | 1 Comment | ||
Covestor | 66.80 | 3/14/2011 | NS | $3.76 | -76.98% | +295.27% | +372.25 | 1 Comment | ||
XMFConnor | 87.02 | 5/16/2012 | 5Y | $4.62 | -81.27% | +282.90% | +364.17 | 0 Comment | ||
finkyfarnes | < 20 | 7/8/2008 | 3M | $1.56 | -44.52% | +318.38% | +362.90 | 0 Comment | ||
stratisticalarb | 61.13 | 4/26/2011 | 1Y | $3.99 | -78.31% | +280.57% | +358.88 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.